These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
735 related articles for article (PubMed ID: 22251451)
1. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451 [TBL] [Abstract][Full Text] [Related]
2. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs). Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872 [TBL] [Abstract][Full Text] [Related]
3. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081 [TBL] [Abstract][Full Text] [Related]
4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Li Y; Birnbaumer L; Teng CT Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987 [TBL] [Abstract][Full Text] [Related]
5. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER. Zekas E; Prossnitz ER BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790 [TBL] [Abstract][Full Text] [Related]
6. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008 [TBL] [Abstract][Full Text] [Related]
7. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Filardo EJ; Quinn JA; Frackelton AR; Bland KI Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440 [TBL] [Abstract][Full Text] [Related]
8. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells. Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368 [TBL] [Abstract][Full Text] [Related]
9. ERα-targeted endocrine therapy, resistance and the role of GPER. Pepermans RA; Prossnitz ER Steroids; 2019 Dec; 152():108493. PubMed ID: 31518595 [TBL] [Abstract][Full Text] [Related]
10. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer. Mo Z; Liu M; Yang F; Luo H; Li Z; Tu G; Yang G Breast Cancer Res; 2013 Nov; 15(6):R114. PubMed ID: 24289103 [TBL] [Abstract][Full Text] [Related]
11. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773 [TBL] [Abstract][Full Text] [Related]
12. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells. Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A Gene; 2023 Aug; 877():147548. PubMed ID: 37279863 [TBL] [Abstract][Full Text] [Related]
14. ER-mediated anti-tumor effects of shikonin on breast cancer. Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985 [TBL] [Abstract][Full Text] [Related]
15. Identification of Breast Cancer Inhibitors Specific for G Protein-Coupled Estrogen Receptor (GPER)-Expressing Cells. Aiello F; Carullo G; Giordano F; Spina E; Nigro A; Garofalo A; Tassini S; Costantino G; Vincetti P; Bruno A; Radi M ChemMedChem; 2017 Aug; 12(16):1279-1285. PubMed ID: 28520140 [TBL] [Abstract][Full Text] [Related]
16. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Scaling AL; Prossnitz ER; Hathaway HJ Horm Cancer; 2014 Jun; 5(3):146-160. PubMed ID: 24718936 [TBL] [Abstract][Full Text] [Related]
18. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
20. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis. Marchese S; Silva E PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]